Pharmacotherapy is an important and often underutilized approach in the treatment of addictive disease. Scientists at the SRC are conducting a number of research studies that test new medications for the treatment of addiction and that seek to examine the effective use of approved medications in novel settings. In addition, further research in this area examines the benefits of adding counseling to medication therapy. Through these studies, SRC scientists are hoping to expand the availability of effective treatments to addicted individuals and thereby improve patient outcomes, as well as public health and safety.
FRI scientists currently working within this field include the following:
|Lead Scientists||Robert P. Schwartz, M.D.|
|Collaborating Scientists||Michael S. Gordon, D.P.A.
Jerome H. Jaffe, M.D.
Timothy W. Kinlock, Ph.D.